Rohto Pharmaceutical Co.,Ltd.
4527.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | ¥31,005 | ¥30,937 | ¥34,290 | ¥27,953 |
| Dep. & Amort. | ¥13,143 | ¥8,687 | ¥7,801 | ¥7,673 |
| Deferred Tax | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock-Based Comp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Change in WC | -¥6,032 | -¥8,856 | -¥11,277 | ¥458 |
| Other Non-Cash | -¥1,199 | ¥3,477 | ¥110 | -¥8,834 |
| Operating Cash Flow | ¥36,917 | ¥34,245 | ¥30,924 | ¥27,250 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -¥10,561 | -¥7,979 | -¥9,908 | -¥11,328 |
| Net Acquisitions | ¥31,646 | ¥0 | -¥1,582 | -¥1,203 |
| Inv. Purchases | -¥9,537 | -¥9,080 | -¥5,940 | -¥5,615 |
| Inv. Sales/Matur. | ¥5,974 | ¥1,704 | ¥2,641 | ¥1,963 |
| Other Inv. Act. | -¥106,692 | -¥962 | ¥1,613 | -¥223 |
| Investing Cash Flow | -¥89,170 | -¥16,317 | -¥13,176 | -¥16,406 |
| Financing Activities | – | – | – | – |
| Debt Repay. | ¥31,907 | -¥1,223 | -¥9,882 | ¥7,590 |
| Stock Issued | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock Repurch. | -¥5,000 | ¥0 | ¥0 | ¥0 |
| Dividends Paid | -¥7,072 | -¥5,475 | -¥4,676 | -¥3,422 |
| Other Fin. Act. | ¥15,484 | -¥7,086 | -¥1,641 | -¥698 |
| Financing Cash Flow | ¥35,319 | -¥13,784 | -¥16,199 | ¥3,470 |
| Forex Effect | ¥3,374 | ¥4,703 | ¥5,236 | ¥4,335 |
| Net Chg. in Cash | -¥13,341 | ¥8,871 | ¥6,786 | ¥18,651 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | ¥86,562 | ¥77,691 | ¥70,905 | ¥52,254 |
| End Cash | ¥73,221 | ¥86,562 | ¥77,691 | ¥70,905 |
| Free Cash Flow | ¥27,837 | ¥25,333 | ¥21,016 | ¥15,922 |